title: Deamidation alters the structure and decreases the stability of human lens betaA3-crystallin.
abstract: According to the World Health Organization, cataracts account for half of the blindness in the world, with the majority occurring in developing countries. A cataract is a clouding of the lens of the eye due to light scattering of precipitated lens proteins or aberrant cellular debris. The major proteins in the lens are crystallins, and they are extensively deamidated during aging and cataracts. Deamidation has been detected at the domain and monomer interfaces of several crystallins during aging. The purpose of this study was to determine the effects of two potential deamidation sites at the predicted interface of the betaA3-crystallin dimer on its structure and stability. The glutamine residues at the reported in vivo deamidation sites of Q180 in the C-terminal domain and at the homologous site Q85 in the N-terminal domain were substituted with glutamic acid residues by site-directed mutagenesis. Far-UV and near-UV circular dichroism spectroscopy indicated that there were subtle differences in the secondary structure and more notable differences in the tertiary structure of the mutant proteins compared to that of the wild type betaA3-crystallin. The Q85E/Q180E mutant also was more susceptible to enzymatic digestion, suggesting increased solvent accessibility. These structural changes in the deamidated mutants led to decreased stability during unfolding in urea and increased precipitation during heat denaturation. When simulating deamidation at both residues, there was a further decrease in stability and loss of cooperativity. However, multiangle-light scattering and quasi-elastic light scattering experiments showed that dimer formation was not disrupted, nor did higher-order oligomers form. These results suggest that introducing charges at the predicted domain interface in the betaA3 homodimer may contribute to the insolubilization of lens crystallins or favor other, more stable, crystallin subunit interactions.
authors.affiliation: Department of Integrative Biosciences, School of Dentistry, Oregon Health & Science University, 611 SW Campus Drive, Portland, Oregon 97239-3098, USA.
authors.forename: Takumi
authors.initials: T
authors.lastname: Takata
authors.forename: Julie T
authors.initials: JT
authors.lastname: Oxford
authors.forename: Theodore R
authors.initials: TR
authors.lastname: Brandon
authors.forename: Kirsten J
authors.initials: KJ
authors.lastname: Lampi
mesh_terms: D019943:Amino Acid Substitution / Q000235:genetics; D011232:Chemical Precipitation; D002852:Chromatography, Ion Exchange; D002942:Circular Dichroism; D019281:Dimerization; D018698:Glutamic Acid / Q000737:chemistry; D005973:Glutamine / Q000737:chemistry*; D006801:Humans; D066298:In Vitro Techniques; D007908:Lens, Crystalline / Q000737:chemistry*; D008958:Models, Molecular; D016297:Mutagenesis, Site-Directed / Q000379:methods; D011485:Protein Binding; D011487:Protein Conformation; D011489:Protein Denaturation; D017510:Protein Folding; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D012542:Scattering, Radiation; D014508:Urea / Q000737:chemistry; D038205:beta-Crystallin A Chain / Q000737:chemistry* / Q000378:metabolism
chemical_list: C489108:CRYBA1 protein, human; D011994:Recombinant Proteins; D038205:beta-Crystallin A Chain; D005973:Glutamine; D018698:Glutamic Acid; D014508:Urea